why choose us

First received: January 14, 2026

Clinical Trial: Spexin and Phoenixin-20 in Girls With Central Precocious Puberty

Study Status: COMPLETED

Recruit Status: COMPLETED

Condition: Central Precocious Puberty (CPP)

Study Type: OBSERVATIONAL


Official Title: Comparison of Spexin and Phoenixin-20 Levels in Girls With Central Precocious Puberty, Premature Thelarche, and Healthy Controls

Brief Summary: Central precocious puberty (CPP) is characterized by the early activation of the hypothalamic-pituitary-gonadal axis in girls and may be difficult to distinguish from benign variants such as premature thelarche.Spexin and phoenixin-20 are novel neuropeptides that have been suggested to play roles in reproductive axis regulation.The aim of this study was to compare serum spexin and phoenixin-20 levels among girls with central precocious puberty, girls with premature thelarche, and healthy age-matched controls.The…

Read more